Pierre Fabre APIs's technical paper on Pharmaceutical Manufacturing News

Packaging
- Packaging News
- Packaging P.R
  - IMA Safe
  - Curtec
  - Bormioli Rocco
  - Astech
  - Rexam PLC
  - IMA
  - Fred Hassan
  - Rexam
  - Alcan
  - CurTec
  - Rexam
  - Marchesini Group
  - Bormioli Rocco
  - Pharmatech
  - FrieslandCampina
- Packaging Profile
- Technical Paper
  - Rexam
  - CurTec Packaging
  - CurTec
  - Rexam Pharma
  - CurTec
  - Rexam Pharma
  - Schott
  - Innovatum
  - Alcan
APIs & Excipients
Processing
- Process News
  - Thermo
  - Cipla
  - Interview F.Hassan
  - Toll Manuf
  - Aarkstore
  - Aseptic Filling
  - Nycomed
  - DSM
  - DSM
  - Onyx
  - Decontamination
  - Linde Group
  - Novartis
  - Sciniopharm
  - INTERPHEX
- Process P.R
  - NI
  - GEA
  - Thermo
  - Sensitech
  - Unilife
  - amixon® GmbH
  - Thermo
  - DuPont
  - Capsugel
  - Syrris
  - Malvern
  - Univar
  - Lonza
  - Werum
  - Formatech, Inc.
- Process Profile
- Technical Paper
Generics
- Generic News
- Generic P.R
  - Arena Pharma
  - Fred Hassan
  - Avrio
  - Abbott
  - Watson Pharma
  - FDA
  - FrieslandCampina
  - Biosimilars
  - AHF
  - Cphi Worldwide
  - BORMIOLI
  - Valturna®
  - FORTESTA
  - Generic PLAN B(R)
  - DUROLANE(R)
- Generic Profile
  - Chemische Werke
  - Elder Pharma
  - Axcell Bio
  - Sanofi
  - Alcon
  - Novartis
  - Teva
- Technical Paper
  - Mylan
  - FDA
  - Sandoz
  - PRA
Outsourcing
- CMO News
  - PHRMA
  - Interview F.Hassan
  - Nycomed
  - ReAgent
  - Consulting
  - DuPont
  - SPIRIVA
  - Flexible Medical
  - Emerging Markets
  - Outsourcing
  - Novartis
  - IDC
  - INTERPHEX
  - Health Robotics
  - Freeman Tech
- CMO P.R
  - Nycomed
  - Curtec
  - Fred Hassan
  - Lonza
  - PPD
  - Novus
  - Werum
  - Watson Pharma
  - Arium Pro
  - Catalent
  - BioTek Instr
  - Canadameds
  - FDA
  - Perrigo Company
  - GTZ - Merck KGaA
- CMO Profile
- Technical Paper
  - Rexam
  - CurTec On QA
  - CurTec Packaging
  - CurTec
  - Chemische Werke
  - PRA
  - Capgemini
QA/QC & Trends
- QA/QC News
  - Napp Pharma
  - PHRMA
  - FDA Audits
  - Interview F.Hassan
  - Norwich Pharma
  - Nycomed
  - Sensient
  - Alcon Inc
  - SPIRIVA
  - Emerging Markets
  - Novartis
  - Sciniopharm
  - IDC
  - INTERPHEX
  - FDA
- QA/QC P.R
  - Bayer
  - Thermo
  - Ethex Corp
  - Paladin
  - Merck KGaA
  - Merck KGaA
  - Rexam PLC
  - DISHMAN
  - Fred Hassan
  - Alcon
  - Bosch
  - Ricerca Bio
  - PPD
  - PhRMA
  - Sartorius
- QA/QC Profile
- Technical Paper
Editorial
- Perspectives
- Monthly Products
Events
Subscribe
Consult us

Latest news headlines : Thermo Fisher Scientific Offers Custom Cleaning Services - Napp Moves Into Top 5 in Sunday Times Best Companies List - Medical Innovation, New Therapies Helping To Extend American Lives -

Pierre Fabre APIs's technical paper

Abstract from Pierre Fabre APIs's Technical Paper :

Pierre Fabre Medicament, Active Ingredients divisions

Pierre Fabre presents the company's work relating to Active Pharmaceutical Ingredients.

Through this brochure, the company presents its Bioavailability enhancement, extraction, semisynthesis, purification and cytotoxic apis capabilities.

To access Pierre Fabre APIs's technical paper, please complete the following fields :

E-Mail address :

Title :

Prof

Mrs

Full name :

Job title :

Company name :

Company Size :

Country :

Area of expertise :

Request additional information :

NEW! Send your Press Release for publication - Related Pharmaceutical & Lifesciences websites in Asia: Asia Manufacturing Pharma | Asia Lifesciences

Pierre Fabre Medicament, Active Ingredients divisions Pierre Fabre presents the company's work relating to Active Pharmaceutical Ingredients. Through this brochure, the company presents its Bioavailability enhancement, extraction, semisynthesis, purification and cytotoxic apis capabilities.

Pierre Fabre Medicament, Active Ingredients divisions

Pierre Fabre presents the company's work relating to Active Pharmaceutical Ingredients.

Through this brochure, the company presents its Bioavailability enhancement, extraction, semisynthesis, purification and cytotoxic apis capabilities.